252 related articles for article (PubMed ID: 27031464)
1. An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model.
Nelson RE; Jones M; Leecaster M; Samore MH; Ray W; Huttner A; Huttner B; Khader K; Stevens VW; Gerding D; Schweizer ML; Rubin MA
PLoS One; 2016; 11(3):e0152248. PubMed ID: 27031464
[TBL] [Abstract][Full Text] [Related]
2. A simulation-based assessment of strategies to control Clostridium difficile transmission and infection.
Rubin MA; Jones M; Leecaster M; Khader K; Ray W; Huttner A; Huttner B; Toth D; Sablay T; Borotkanics RJ; Gerding DN; Samore MH
PLoS One; 2013; 8(11):e80671. PubMed ID: 24278304
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection.
Barker AK; Scaria E; Safdar N; Alagoz O
JAMA Netw Open; 2020 Aug; 3(8):e2012522. PubMed ID: 32789514
[TBL] [Abstract][Full Text] [Related]
4. Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.
Barker AK; Alagoz O; Safdar N
Clin Infect Dis; 2018 Apr; 66(8):1192-1203. PubMed ID: 29112710
[TBL] [Abstract][Full Text] [Related]
5. An agent-based simulation model for Clostridium difficile infection control.
Codella J; Safdar N; Heffernan R; Alagoz O
Med Decis Making; 2015 Feb; 35(2):211-29. PubMed ID: 25112595
[TBL] [Abstract][Full Text] [Related]
6. Association of Visitor Contact Precautions With Estimated Hospital-Onset Clostridioides difficile Infection Rates in Acute Care Hospitals.
Scaria E; Barker AK; Alagoz O; Safdar N
JAMA Netw Open; 2021 Feb; 4(2):e210361. PubMed ID: 33635330
[TBL] [Abstract][Full Text] [Related]
7. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study.
Stephenson B; Lanzas C; Lenhart S; Ponce E; Bintz J; Dubberke ER; Day J
BMC Infect Dis; 2020 Oct; 20(1):799. PubMed ID: 33115427
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study.
Stone SP; Fuller C; Savage J; Cookson B; Hayward A; Cooper B; Duckworth G; Michie S; Murray M; Jeanes A; Roberts J; Teare L; Charlett A
BMJ; 2012 May; 344():e3005. PubMed ID: 22556101
[TBL] [Abstract][Full Text] [Related]
9. The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program.
Slayton RB; Scott RD; Baggs J; Lessa FC; McDonald LC; Jernigan JA
Infect Control Hosp Epidemiol; 2015 Jun; 36(6):681-7. PubMed ID: 25783204
[TBL] [Abstract][Full Text] [Related]
10. Reduction in the incidence of hospital-acquired Clostridium difficile infection through infection control interventions other than the restriction of antimicrobial use.
You E; Song H; Cho J; Lee J
Int J Infect Dis; 2014 May; 22():9-10. PubMed ID: 24583565
[TBL] [Abstract][Full Text] [Related]
11. Novel strategies for enhanced removal of persistent Bacillus anthracis surrogates and Clostridium difficile spores from skin.
Nerandzic MM; Rackaityte E; Jury LA; Eckart K; Donskey CJ
PLoS One; 2013; 8(7):e68706. PubMed ID: 23844234
[TBL] [Abstract][Full Text] [Related]
12. Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission.
Stephenson B; Lanzas C; Lenhart S; Day J
J Math Biol; 2017 Dec; 75(6-7):1693-1713. PubMed ID: 28484801
[TBL] [Abstract][Full Text] [Related]
13. Wide variation in adoption of screening and infection control interventions for multidrug-resistant organisms: a national study.
Pogorzelska M; Stone PW; Larson EL
Am J Infect Control; 2012 Oct; 40(8):696-700. PubMed ID: 23021413
[TBL] [Abstract][Full Text] [Related]
14. Measures to control and prevent Clostridium difficile infection.
Gerding DN; Muto CA; Owens RC
Clin Infect Dis; 2008 Jan; 46 Suppl 1():S43-9. PubMed ID: 18177221
[TBL] [Abstract][Full Text] [Related]
15. Reducing
Barker AK; Scaria E; Alagoz O; Sethi AK; Safdar N
Infect Control Hosp Epidemiol; 2020 May; 41(5):522-530. PubMed ID: 32052722
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of nosocomial Clostridium difficile infection.
Samore MH
Compr Ther; 1993; 19(4):151-6. PubMed ID: 8261769
[TBL] [Abstract][Full Text] [Related]
17. Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence.
Hsu J; Abad C; Dinh M; Safdar N
Am J Gastroenterol; 2010 Nov; 105(11):2327-39; quiz 2340. PubMed ID: 20606676
[TBL] [Abstract][Full Text] [Related]
18. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission.
Johnson S; Gerding DN; Olson MM; Weiler MD; Hughes RA; Clabots CR; Peterson LR
Am J Med; 1990 Feb; 88(2):137-40. PubMed ID: 2301439
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Stewardship and Environmental Decontamination for the Control of Clostridium difficile Transmission in Healthcare Settings.
Bintz J; Lenhart S; Lanzas C
Bull Math Biol; 2017 Jan; 79(1):36-62. PubMed ID: 27826877
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Infection due to Clostridium (Clostridioides) difficile.
Krishna A; Chopra T
Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
